Viral Genetics Inc.'s FDA Filing Going Viral

Share Article

The Dean of CollegeStock.com announced a mandatory study session for all CollegeStock.com Honors Students as a result of recent article discussing Viral Genetics Inc.'s (Pink Sheets: VRAL) Investigatory New Drug (IND) filing with the FDA.

TFN Reader Grapevine: There's Something about Viral Genetics, Inc. (VRAL)

CollegeStock.com: The Dean announced a mandatory study session for all CollegeStock.com Honors Students as a result of the recent article in Today's Financial News referencing Viral Genetics Inc. (Pink Sheets: VRAL) Investigatory New Drug (IND) filing with the FDA.

The article, "TFN Reader Grapevine: There's Something about Viral Genetics, Inc. (VRAL)" was published on Tuesday afternoon right as Viral Genetics shares rose as much as 30% on trading volume 1,000% higher than the 10-day average.

According to the article, "rumor has it that they are planning something big - heard about them filing with the FDA re: investigatory new drug filing within the month."

"This is the first publicly available information referencing Viral Genetics Inc.'s (VRAL) IND filing with the FDA for their VGV-1 drug and its important that students know all the facts about the FDA process," added Dean.

The Dean is urging anyone interested in learning more about the IND filing and FDA approval process for Viral's VGV-1 drug to sign up to become an Honors Student at CollegeStock.com.

About Viral Genetics:
Viral Genetics (Pink Sheets: VRAL) discovers and develops drug therapies to treat infectious, autoimmune, and immunological deficiency disorders using its thymus nuclear protein compound (TNP). The company recently entered into an Exclusive License Agreement with the University of Colorado and V-Clip Pharmaceuticals (a subsidiary of the Company) to license technology developed by M. Karen Newell, Ph. D., which appears to explain TNP and provide a means to optimize therapies based on TNP for future clinical trials. Visit http://www.viralgenetics.com for more information.

About The CollegeStock Group
The CollegeStock Group, Inc. is the owner of http://collegestock.com/. CollegeStock.com is the Internet's #1 destination for stock market education. With a network of over 100,000 followers, CollegeStock.com focuses on speculative investing. Staying true to their motto of "Higher Learning for a Higher Net Worth," The CollegeStock Group is committed to focusing on real world methods on making money in the stock market and continues to be a reliable source for the best stock picks on the Internet.

Not a Broker/Dealer or Financial Advisor
CollegeStock Group, Inc. ("CollegeStock") is not a registered investment advisor or broker-dealer. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.

Details of Compensation Received
CollegeStock has purchased five hundred and eighty seven thousand shares of Viral Genetics, Inc. (Pink Sheets: VRAL) in the open market and reserves the right to sell at anytime without notice.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Thomas McCarthy
Visit website